Stay updated on Nintedanib for Progressive Fibrosing ILD Clinical Trial
Sign up to get notified when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.

Latest updates to the Nintedanib for Progressive Fibrosing ILD Clinical Trial page
- Check4 days agoChange DetectedLocations section updated to include a broader list of study sites across the United States and Canada, and a revision tag v3.3.3.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated to v3.3.2. The previous revision v3.3.1 has been removed.SummaryDifference0.0%

- Check32 days agoChange DetectedPublications section updated: added that publications are automatically filled from PubMed. The revision label was updated to v3.3.1, replacing the previous text referring to PubMed publications and revision v3.2.0.SummaryDifference0.0%

- Check40 days agoChange DetectedDeletion of the government funding status notice at the top of the ClinicalTrials.gov page for NCT02999178. The core study content and study details remain unchanged.SummaryDifference0.2%

- Check54 days agoChange DetectedAdded posted results for the INBUILD PF-ILD study, detailing primary and key secondary outcomes and time-to-event analyses.SummaryDifference0.2%

- Check83 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference1%

Stay in the know with updates to Nintedanib for Progressive Fibrosing ILD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.